More tax exemption plan for R&D spending to take place in next January

Published: 2007-12-06 07:00:00

Updated: 2007-12-06 07:00:00

With the National Assembly to delay 2008 budget bill amid political parties' confrontation ahead of the Dec. 19 presidential election, the government's plan to expand tax exemptions for corporate investment in research and development (R&D) as part of efforts to stimulate pharmaceutical companies...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK